{"DataElement":{"publicId":"7148740","version":"1","preferredName":"Myelofibrosis World Health Organization Classification European Consensus on Grading of Bone Marrow Fibrosis Type","preferredDefinition":"A description of the Myelofibrosis WHO European consensus classification bone marrow grade.","longName":"7144537v1.0:7148735v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7144537","version":"1","preferredName":"Myelofibrosis World Health Organization Classification European Consensus on Grading of Bone Marrow Fibrosis","preferredDefinition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003_A United Nations agency established to coordinate international health activities and to help governments improve health services._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._A grading scheme that includes both a qualitative (reticulin or collagen) and quantitative evaluation of bone marrow fibrosis comprising four increasing categories.","longName":"2821284v1.0:7148850v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2821284","version":"1","preferredName":"Myelofibrosis","preferredDefinition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003","longName":"C3248","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelofibrosis","conceptCode":"C3248","definition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F5C5E78-DC25-DC01-E040-BB89AD43564F","latestVersionIndicator":"Yes","beginDate":"2008-12-31","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-12-31","modifiedBy":"ONEDATA","dateModified":"2008-12-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7148850","version":"1","preferredName":"World Health Organization Classification European Consensus on Grading of Bone Marrow Fibrosis","preferredDefinition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.:A grading scheme that includes both a qualitative (reticulin or collagen) and quantitative evaluation of bone marrow fibrosis comprising four increasing categories.","longName":"C75419:C25161:C168575","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization","conceptCode":"C75419","definition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"European Consensus on Grading of Bone Marrow Fibrosis","conceptCode":"C168575","definition":"A grading scheme that includes both a qualitative (reticulin or collagen) and quantitative evaluation of bone marrow fibrosis comprising four increasing categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD4E3AA-E4CF-0764-E053-F662850AA9F4","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C5D4266-B030-12E4-E053-F662850AAFBA","latestVersionIndicator":"Yes","beginDate":"2020-01-17","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-17","modifiedBy":"MALUMK","dateModified":"2020-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7148735","version":"1","preferredName":"Myelofibrosis Type Classification European Consensus on Grading of Bone Marrow Fibrosis","preferredDefinition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003_The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems._Something distinguishable as an identifiable class based on common qualities._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._A grading scheme that includes both a qualitative (reticulin or collagen) and quantitative evaluation of bone marrow fibrosis comprising four increasing categories.","longName":"7148735v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MF-0","valueDescription":"Marrow Fibrosis Grade 0","ValueMeaning":{"publicId":"7148736","version":"1","preferredName":"Marrow Fibrosis Grade 0","longName":"7148736","preferredDefinition":"Scattered linear reticulin with no intersections (crossovers) corresponding to normal bone marrow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Marrow Fibrosis Grade 0","conceptCode":"C168576","definition":"Scattered linear reticulin with no intersections (crossovers) corresponding to normal bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD27B19-B0EB-42D1-E053-F662850A9D24","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD27B19-B104-42D1-E053-F662850A9D24","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"},{"value":"MF-1","valueDescription":"Marrow Fibrosis Grade 1","ValueMeaning":{"publicId":"7148737","version":"1","preferredName":"Marrow Fibrosis Grade 1","longName":"7148737","preferredDefinition":"Loose network of reticulin with many intersections, especially in perivascular areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Marrow Fibrosis Grade 1","conceptCode":"C168577","definition":"Loose network of reticulin with many intersections, especially in perivascular areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD27B19-B110-42D1-E053-F662850A9D24","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD27B19-B129-42D1-E053-F662850A9D24","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"},{"value":"MF-2","valueDescription":"Marrow Fibrosis Grade 2","ValueMeaning":{"publicId":"7148738","version":"1","preferredName":"Marrow Fibrosis Grade 2","longName":"7148738","preferredDefinition":"Diffuse and dense increase in reticulin with extensive intersections, occasionally with focal bundles of thick fibers mostly consistent with collagen and/or focal osteosclerosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Marrow Fibrosis Grade 2","conceptCode":"C168578","definition":"Diffuse and dense increase in reticulin with extensive intersections, occasionally with focal bundles of thick fibers mostly consistent with collagen and/or focal osteosclerosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD27B19-B135-42D1-E053-F662850A9D24","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD27B19-B14E-42D1-E053-F662850A9D24","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"},{"value":"MF-3","valueDescription":"Marrow Fibrosis Grade 3","ValueMeaning":{"publicId":"7148739","version":"1","preferredName":"Marrow Fibrosis Grade 3","longName":"7148739","preferredDefinition":"Diffuse and dense increase in reticulin with extensive intersections and coarse bundles of thick fibers mostly consistent with collagen, usually associated with osteosclerosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Marrow Fibrosis Grade 3","conceptCode":"C168579","definition":"Diffuse and dense increase in reticulin with extensive intersections and coarse bundles of thick fibers mostly consistent with collagen, usually associated with osteosclerosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD27B19-B15A-42D1-E053-F662850A9D24","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD27B19-B173-42D1-E053-F662850A9D24","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7148951","version":"1","preferredName":"Myelofibrosis European Consensus on Grading of Bone Marrow Fibrosis Type","preferredDefinition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003:A grading scheme that includes both a qualitative (reticulin or collagen) and quantitative evaluation of bone marrow fibrosis comprising four increasing categories.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3248:C168575:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelofibrosis","conceptCode":"C3248","definition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"European Consensus on Grading of Bone Marrow Fibrosis","conceptCode":"C168575","definition":"A grading scheme that includes both a qualitative (reticulin or collagen) and quantitative evaluation of bone marrow fibrosis comprising four increasing categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD4C04B-F57B-7E86-E053-F662850A9F30","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD27B19-B0D4-42D1-E053-F662850A9D24","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"MALUMK","dateModified":"2020-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"WHO_BM_FIBROSIS_TYP","type":"OID, NCIP","context":"NCIP"}],"ReferenceDocuments":[{"name":"Specify the grade","type":"Alternate Question Text","description":"Specify the grade","url":null,"context":"NHLBI"},{"name":"Specify the grade","type":"Application Standard Question Text","description":"Specify the grade","url":null,"context":"NHLBI"},{"name":"Specify the Grade","type":"Alternate Question Text","description":"Specify the Grade","url":null,"context":"NHLBI"},{"name":"What is the Myelofibrosis WHO","type":"Preferred Question Text","description":"What is the Myelofibrosis WHO European consensus classification bone marrow grade?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD27B19-B180-42D1-E053-F662850A9D24","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-01-23","modifiedBy":"MALUMK","dateModified":"2020-05-11","changeDescription":".System generated def displayed as alt def. 05/11/2020 KMM; .System generated def displayed as alt def. 05/11/2020 KMM; .System generated def displayed as alt def.; System generated def displayed as alt def. 01/23/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}